News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
725,589 Results
Type
Article (41523)
Company Profile (267)
Press Release (683789)
Multimedia
Podcasts (80)
Webinars (17)
Section
Business (205732)
Career Advice (2023)
Deals (35700)
Drug Delivery (110)
Drug Development (81592)
Employer Resources (173)
FDA (16588)
Job Trends (14993)
News (348075)
Policy (32898)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2593)
Accelerated approval (31)
Adcomms (25)
Allergies (137)
Alliances (49761)
ALS (167)
Alzheimer's disease (1658)
Antibody-drug conjugate (ADC) (305)
Approvals (16853)
Artificial intelligence (503)
Autoimmune disease (143)
Automation (37)
Bankruptcy (362)
Best Places to Work (11673)
BIOSECURE Act (20)
Biosimilars (187)
Biotechnology (174)
Bladder cancer (157)
Brain cancer (57)
Breast cancer (633)
Cancer (4768)
Cardiovascular disease (396)
Career advice (1708)
Career pathing (35)
CAR-T (275)
CDC (44)
Celiac Disease (2)
Cell therapy (729)
Cervical cancer (36)
Clinical research (69669)
Collaboration (1669)
Company closure (4)
Compensation (1142)
Complete response letters (54)
COVID-19 (2708)
CRISPR (87)
C-suite (813)
Cystic fibrosis (144)
Data (6158)
Decentralized trials (2)
Denatured (25)
Depression (130)
Diabetes (496)
Diagnostics (6683)
Digital health (44)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (241)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (225)
Earnings (90561)
Editorial (55)
Employer branding (21)
Employer resources (151)
Events (117954)
Executive appointments (964)
FDA (19678)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1447)
Gene editing (191)
Generative AI (42)
Gene therapy (584)
GLP-1 (963)
Government (4661)
Grass and pollen (6)
Guidances (383)
Healthcare (19125)
HIV (55)
Huntington's disease (44)
IgA nephropathy (81)
Immunology and inflammation (244)
Immuno-oncology (54)
Indications (103)
Infectious disease (2966)
Inflammatory bowel disease (187)
Inflation Reduction Act (14)
Influenza (110)
Intellectual property (243)
Interviews (315)
IPO (16709)
IRA (49)
Job creations (3656)
Job search strategy (1428)
JPM (56)
Kidney cancer (15)
Labor market (83)
Layoffs (546)
Leadership (30)
Legal (7995)
Liver cancer (94)
Longevity (14)
Lung cancer (639)
Lymphoma (371)
Machine learning (42)
Management (59)
Manufacturing (777)
MASH (162)
Medical device (14065)
Medtech (14118)
Mergers & acquisitions (20048)
Metabolic disorders (1252)
Multiple sclerosis (155)
NASH (16)
Neurodegenerative disease (307)
Neuropsychiatric disorders (86)
Neuroscience (2869)
Neurotech (1)
NextGen: Class of 2026 (6573)
Non-profit (4532)
Now hiring (65)
Obesity (586)
Opinion (256)
Ovarian cancer (164)
Pain (201)
Pancreatic cancer (223)
Parkinson's disease (279)
Partnered (33)
Patents (486)
Patient recruitment (471)
Peanut (55)
People (59092)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21721)
Phase 2 (30669)
Phase 3 (22855)
Pipeline (5080)
Policy (278)
Postmarket research (2572)
Preclinical (9205)
Press Release (64)
Prostate cancer (237)
Psychedelics (47)
Radiopharmaceuticals (278)
Rare diseases (818)
Real estate (5991)
Recruiting (69)
Regulatory (24551)
Reports (51)
Research institute (2394)
Resumes & cover letters (351)
Rett syndrome (27)
RNA editing (16)
RSV (76)
Schizophrenia (147)
Series A (237)
Series B (185)
Service/supplier (11)
Sickle cell disease (95)
Special edition (21)
Spinal muscular atrophy (157)
Sponsored (41)
Startups (3641)
State (2)
Stomach cancer (17)
Supply chain (105)
Tariffs (84)
The Weekly (53)
Vaccines (984)
Venture capital (86)
Weight loss (376)
Women's health (87)
Worklife (18)
Date
Last 7 days (593)
Last 30 days (1949)
Last 365 days (29848)
2026 (2823)
2025 (30307)
2024 (35354)
2023 (40263)
2022 (51387)
2021 (55916)
2020 (54337)
2019 (46829)
2018 (35277)
2017 (32344)
2016 (31762)
2015 (37809)
2014 (31528)
2013 (26584)
2012 (28829)
2011 (29478)
2010 (27574)
Location
Africa (739)
Alabama (83)
Alaska (7)
Arizona (305)
Arkansas (13)
Asia (39554)
Australia (6449)
California (11187)
Canada (3253)
China (1083)
Colorado (472)
Connecticut (470)
Delaware (332)
Europe (85115)
Florida (1660)
Georgia (356)
Hawaii (3)
Idaho (61)
Illinois (855)
India (62)
Indiana (515)
Iowa (22)
Japan (418)
Kansas (125)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1372)
Massachusetts (8010)
Michigan (320)
Minnesota (625)
Mississippi (6)
Missouri (133)
Montana (31)
Nebraska (28)
Nevada (122)
New Hampshire (82)
New Jersey (2997)
New Mexico (28)
New York (2944)
North Carolina (1447)
North Dakota (8)
Northern California (5457)
Ohio (330)
Oklahoma (21)
Oregon (42)
Pennsylvania (2254)
Puerto Rico (22)
Rhode Island (48)
South America (1111)
South Carolina (65)
South Dakota (1)
Southern California (4347)
Tennessee (172)
Texas (1724)
United States (39687)
Utah (334)
Vermont (1)
Virginia (259)
Washington D.C. (81)
Washington State (914)
West Virginia (4)
Wisconsin (106)
Wyoming (2)
725,589 Results for "minerva surgical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Minerva Neurosciences to Host Virtual KOL Event to Discuss Roluperidone: From Unmet Need to Reality – Potentially the First Treatment for Patients with Negative Symptoms of Schizophrenia, on February 3, 2026
January 27, 2026
·
7 min read
Press Releases
Minerva Neurosciences Appoints Dr. Inderjit Kaul to the Company’s Board of Directors
November 20, 2025
·
7 min read
Press Releases
Minerva Neurosciences Reports Third Quarter 2025 Financial Results and Business Updates
November 6, 2025
·
8 min read
Press Releases
XenoSTART and Minerva Imaging Expand Partnership to Deliver Integrated PDX-Radiopharmaceutical Drug Development Platform
October 3, 2025
·
5 min read
Press Releases
Minerva Neurosciences Provides Business Updates and Second Quarter Financial Results
August 15, 2025
·
8 min read
Business
Minerva Surgical Reports Third Quarter 2023 Financial Results
Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a women’s health company focused on solutions to meet the distinct uterine healthcare needs of women, today reported third quarter financial results for the period ended September 30, 2023.
November 13, 2023
·
10 min read
Press Releases
Sanara MedTech Inc. Receives Innovative Technology Contract from Vizient for BIASURGE® Advanced Surgical Solution
January 8, 2026
·
6 min read
Business
Minerva Surgical Reports Second Quarter 2023 Financial Results
Minerva Surgical, Inc. reported second quarter financial results for the period ended June 30, 2023.
August 2, 2023
·
10 min read
Press Releases
Minerva Neurosciences Announces Financing of up to $200 Million to Advance Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia Through a Phase 3 Confirmatory Trial and Resubmission of its New Drug Application and Preparation for US Commercial Launch, if Approved
October 22, 2025
·
12 min read
Press Releases
Sanara MedTech Inc. Announces Strategic Realignment to Focus on Surgical Business
November 11, 2025
·
5 min read
1 of 72,559
Next
